Bellevue Group »

Arcus Biosciences Incorporated shares owned by Bellevue Group

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Bellevue Group

Quarter filed Position value Share count Share price at filing
2022-12-31 $1.4M 66k 20.68
2022-09-30 $2.2M 84k 26.16
2022-06-30 $2.3M 90k 25.34
2022-03-31 $3.5M 112k 31.56
2021-12-31 $3.5M 88k 40.47
2021-09-30 $3.3M 95k 34.87
2021-06-30 $2.1M 75k 27.47
2021-03-31 $2.1M 75k 28.08
2020-12-31 $1.3M 51k 25.96

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Vertex Pharmaceuticals Incorporated (VRTX)
Intuitive Surgical Com New (ISRG)
Intra Cellular Therapies (ITCI)
Moderna (MRNA)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Abbott Laboratories (ABT)
Revolution Medicines (RVMD)
Stryker Corporation (SYK)
Incyte Corporation (INCY)
Axonics Modulation Technolog (AXNX)
Dex (DXCM)

View all positions for Bellevue Group

Top funds holding Arcus Biosciences Incorporated

Vanguard Group
Octagon Capital Advisors
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Decheng Capital
Point72 Asset Management
Goldman Sachs Group
Bnp Paribas Investment Partners
Balyasny Asset Management
Charles Schwab Investment Management
Bank of New York Mellon
Ikarian Capital
Ubs Global Asset Management Americas

View all funds holding Arcus Biosciences Incorporated